Progranulin as a Potential Therapeutic Target in Immune-Mediated Diseases
Yue-Jiao Lan,1,2 Napoleon Bellua Sam,3 Ming-Han Cheng,1 Hai-Feng Pan,4,5 Jian Gao1 1Pediatric Translational Medicine Institute, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China; 2The Second Affiliated Hospital, Dalian Medical...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/94ca2290387d4d6ab0fb7434aed4b006 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Yue-Jiao Lan,1,2 Napoleon Bellua Sam,3 Ming-Han Cheng,1 Hai-Feng Pan,4,5 Jian Gao1 1Pediatric Translational Medicine Institute, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China; 2The Second Affiliated Hospital, Dalian Medical University, Dalian, Liaoning, People’s Republic of China; 3Department of Medical Research and Innovation, School of Medicine, University for Development Studies, Tamale, Ghana; 4Department of Epidemiology & Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, People’s Republic of China; 5Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, People’s Republic of ChinaCorrespondence: Jian GaoPediatric Translational Medicine Institute, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200120, People’s Republic of ChinaEmail gaojian@scmc.com.cn; gaojianayfy@163.comHai-Feng PanDepartment of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Hefei, Anhui, 230032, People’s Republic of ChinaEmail panhaifeng@ahmu.edu.cnAbstract: Progranulin (PGRN), a secretory glycoprotein consisting of 593 amino acid residues, is a key actor and regulator of multiple system functions such as innate immune response and inflammation, as well as tissue regeneration. Recently, there is emerging evidence that PGRN is protective in the development of a variety of immune-mediated diseases, including rheumatoid arthritis (RA), inflammatory bowel disease (IBD), type 1 diabetes mellitus (T1DM) and multiple sclerosis (MS) by regulating signaling pathways known to be critical for immunology, particularly the tumor necrosis factor alpha/TNF receptor (TNF-α/TNFR) signaling pathway. Whereas, the role of PGRN in psoriasis, systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) is controversial. This review summarizes the immunological functions of PGRN and its role in the pathogenesis of several immune-mediated diseases, in order to provide new ideas for developing therapeutic strategies for these diseases.Keywords: PGRN, TNF-α, TNFR, immune-mediated diseases, therapeutic |
|---|